Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic Telangiectasia
NCT00004654
Cardiovascular Abnormalities, Cardiovascular Diseases
View Trial DetailsNCT Number: NCT00004649
OBJECTIVES: I. Collect data regarding the natural history of hereditary hemorrhagic telangiectasia (HHT).
II. Establish genotype-phenotype correlations in HHT. III. Create a database of information for researchers throughout the world.
Looking for future studies?
Notify Me0 year and older
All sexes
Observational
PROTOCOL OUTLINE: Patients complete a self-administered natural history questionnaire in a multiple choice format. Questionnaire is completed by a population consisting of males and females of all ages and ethnic backgrounds.
Data are collected and made available to all researchers.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
National Center for Research Resources (NCRR)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00004654
Cardiovascular Abnormalities, Cardiovascular Diseases
View Trial DetailsNCT00004327
Cardiovascular Abnormalities, Cardiovascular Diseases
View Trial DetailsNCT05269849
Cardiovascular Abnormalities, Cardiovascular Diseases
Toronto, Ontario, Canada
View Trial DetailsNCT04874558
Cardiovascular Abnormalities, Cardiovascular Diseases
Rochester, Minnesota, United States
View Trial Details